Reversal of ethanol-induced testosterone suppression in peripubertal male rats by opiate blockade.
Teenage drinking is a major problem in the United States, as well as abroad. Besides psychosocial implications, ethanol (EtOH) has detrimental effects on the reproductive system. Clinical problems associated with reduced reproductive hormones include osteoporosis, decreased muscle function, anemia, altered immune function, prostate involution, and decreased reproductive abilities. Education coupled with strategies aimed at preventing these deleterious consequences even in the face of continued EtOH intake is extremely important. We have tested the possibility that naltrexone, a drug currently used in patients to decrease alcohol craving, might also prevent the fall in the male hormone, testosterone, caused by EtOH exposure. Rats aged 35 days old (prepubertal), 45 days old (midpubertal), and 55 days old (late pubertal) were injected (intraperitoneally) with either saline, EtOH, naltrexone, or EtOH plus naltrexone. In the two older age groups, EtOH significantly suppressed testosterone, which was prevented by administration of naltrexone. In the youngest animals, there was no treatment effect presumably due to low basal levels of testosterone. EtOH similarly reduced luteinizing hormone (LH), but this suppression was not prevented by naltrexone. There was no consistent effect of any treatment on hypothalamic concentration of pro-LH releasing hormone (RH) (LHRH), LHRH, or on steady-state levels of LHRH mRNA. We conclude that, as animals progress through puberty, EtOH suppresses LH and testosterone. The testosterone decline can be prevented by opiate blockade with naltrexone, an effect primarily seen at gonadal level. Thus, naltrexone, a drug already used clinically to reduce EtOH intake, also has protective physiological effects on the endocrine system.
Department of Medicine, Loyola University Medical Center, Maywood, Illinois 60153, USA.
M A
MA
Emanuele
N
N
LaPaglia
J
J
Steiner
K
K
Jabamoni
M
M
Hansen
L
L
Kirsteins
N V
NV
Emanuele
D000818:Animals; D000431:Ethanol / Q000633:toxicity*; D007031:Hypothalamus / Q000187:drug effects; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors / Q000097:blood; D008297:Male; D009271:Naltrexone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012741:Sexual Maturation / Q000187:drug effects*; D013739:Testosterone / Q000037:antagonists & inhibitors* / Q000097:blood
D009292:Narcotic Antagonists; D000431:Ethanol; D013739:Testosterone; D009271:Naltrexone; D007986:Luteinizing Hormone